Opendata, web and dolomites

ULTIMA

ULTrafast Imaging sensor for Medical Applications

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ULTIMA project word cloud

Explore the words cloud of the ULTIMA project. It provides you a very rough idea of what is the project "ULTIMA" about.

poor    contributes    risk    safe    flight    time    patient    commercialisation    stage    economical    diseases    larger    accurate    cancer    tumors    total    proof    innovation    radiation    doses    throughput    purposes    of    magnitude    modality    functional    breast    lower    assesses    fast    radio    treat    mammography    base    significantly    commercial    pem    combination    scanners    suitable    feasibility    causing    ionizing    close    entity    exposes    considerations    relatively    ratios    screening    improvement    pet    economic    beneficial    safer    performance    crystals    rates    pictures    noise    complementing    benchmarked    limitations    nuclear    deposition    detection    medical    patients    scintillating    considerably    women    emission    vast    benefit    enabled    earlier    tracer    death    photonic    quality    scanning    small    suffers    light    lowering    energy    imaging    signal    life    oncology    positron    comprise    resolution    malignant    dose    efficiency    levels    socio    tomography    output    shortening    biomarkers    ratio    benefits    electronics    mortality    possibilities    diagnose   

Project "ULTIMA" data sheet

The following table provides information about the project.

Coordinator
EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH 

Organization address
address: ESPLANADE DES PARTICULES 1 PARCELLE 11482 DE MEYRIN BATIMENT CADASTRAL 1046
city: GENEVA 23
postcode: 1211
website: www.cern.ch

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2015-PoC
 Funding Scheme ERC-POC
 Starting year 2015
 Duration (year-month-day) from 2015-09-01   to  2017-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH CH (GENEVA 23) coordinator 150˙000.00

Map

 Project objective

Breast cancer is the most common cause of death among women. For lowering the mortality rates and improving life quality, it would be beneficial to diagnose and treat diseases early. Dedicated Positron Emission Tomography (PET) application Positron Emission Mammography (PEM) has been developed for functional medical imaging of specific breast cancer biomarkers. PEM enables accurate detection of small malignant tumors at an earlier stage. However, it suffers from major limitations on becoming suitable for general screening purposes. One of the limitations is that the process exposes the patients to relatively high ionizing radiation doses causing poor total risk-benefit ratios. The project addresses this challenge and contributes to providing safe oncology screening possibilities available for larger patient-base. This project will demonstrate the proof of concept of a state-of-the-art nuclear imaging innovation, which will enable the detection of energy deposition with significantly improved energy and time resolution levels of a PET application. Our approach features high quality pictures with considerably lower radio-tracer dose levels than the current commercial scanners. This is enabled by an order of a magnitude improvement in the signal-to-noise ratio over the current time-of-flight PET scanners. The innovation comprise a novel combination of scintillating and photonic crystals for an improved light output efficiency and fast electronics. As a complementing technology to PEM imaging system, it contributes to safer cancer scanning modality while shortening the scanning process. This results to improved process throughput and vast socio-economic benefits. Within the project, the imaging system technical performance will be benchmarked to a dedicated medical imaging application, such as PEM. The project also addresses the commercialisation considerations, economical feasibility and assesses the system cost. The project will be carried out in close collaboration with a potential exploitation entity.

 Publications

year authors and title journal last update
List of publications.
2017 Bipin Singh, Matthew S. J. Marshall, Shane Waterman, Carlos Pina-Hernandez, Keiko Munechika, Arno Knapitsch, Matteo Salomoni, Paul Lecoq, and Vivek V. Nagarkar
Enhanced Scintillation Light Extraction Using Nanoimprinted Photonic Crystals
published pages: , ISSN: 0018-9499, DOI:
IEEE Transactions of Nuclear Sciences Submitted in February 2017, not 2019-07-25

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ULTIMA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ULTIMA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

ENUF (2019)

Evaluation of Novel Ultra-Fast selective III-V Epitaxy

Read More  

Aware (2019)

Aiding Antibiotic Development with Deep Analysis of Resistance Evolution

Read More  

MITOvTOXO (2020)

Understanding how mitochondria compete with Toxoplasma for nutrients to defend the host cell

Read More